leaders in innovation
OxyContin 5mg, 10mg, 20mg, 40mg and 80mg tablets are indicated for the treatment of severe pain.
OxyNorm 5mg, 10mg and 20mg capsules are indicated for the treatment of severe pain.
OxyNorm injection 10mg/ml solution for injection or infusion is indicated for the treatment of severe pain.
Targin 5mg/2.5mg, 10mg/5mg, 20mg/10mg and 40mg/20mg tablets are indicated for severe pain, which can be adequately managed only with opioid analgesics. The opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut.
Transtec 35mcg/hour, 52.5mcg/hour and 70mcg/hour transdermal patches are indicated in moderate to severe cancer pain and severe pain which does not respond to non-opioid analgesics.
BuTrans 5mcg/hour, 10mcg/hour and 20mcg/hour transdermal patches are indicated for the treatment of non-malignant pain of moderate intensity when an opioid is necessary for obtaining adequate analgesia BuTrans is not suitable for the treatment of acute pain.
Palladone 1.3mg and 2.6mg capsules are indicated in the treatment of severe pain.
MST CONTINUS tablets 5mg, 10mg, 15mg, 30mg and 60mg are indicated for the prolonged relief of severe and intractable pain and in the short term control of post-operative pain.
Sevredol 10mg, 20mg and 50mg tablets are indicated for the treatment of severe pain.
LEADERS IN INNOVATION

Mundipharma Pharmaceuticals associated companies, Mundipharma Research Limited in Cambridge and Mundipharma Research GmbH in Germany, are young,...

PATIENT SUPPORT

What is asthma?
Asthma is a common medical condition that affects the lungs.
More specifically, asthma causes...

PRODUCTS FOR PEOPLE

We are actively involved in the following therapeutic areas: Analgesia, Oncology, and Respiratory.

 

Analgesia is our...

GLOBAL NETWORK

Mundipharma Pharmaceuticals Limited is an Irish company and is part of a network of independent associated companies across Europe. This...

keep me informed

Keep me Informed

Receive Emails about special offers, promotions, products and news.

Mundipharma newsletter

events calendar
Events Calendar
Medical Information &

Medical Information & Adverse Events

Contact Medical Information on:

01 2063800
1800 991 830 (outside office hours)

For Adverse Events email: